Urinary Excretion of Acetylamantadine by Cancer Patients

NCT00755898 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Cancer

Interventions

DRUG: Ingestion of a 200 mg dose of amantadine hydrochloride
DRUG: Ingestion of a 200 mg dose of amantadine hydrochloride

Sponsor

University of Manitoba

Collaborators

[object Object]
[object Object]